Madrigal Pharmaceuticals Inc (MDGL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | MDGL | GRFS | ALPN | ||
| Company | Madrigal Pharmaceuticals Inc | Grifols S.A. ADR | Alpine Immune Sciences Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 212.82 | 6.49 | 64.58 | ||
| High | 225.66 | 6.66 | 64.70 | ||
| Low | 210.10 | 6.43 | 64.50 | ||
| Last | 218.38 | 6.48 | 64.55 | ||
| Change | +4.89 | +0.18 | -0.03 | ||
| % Change | +2.29% | +2.86% | -0.05% | ||
| Volume | 409,500 | 3,409,900 | 3,104,100 | ||
| 20-Day Average Volume | 379,140 | 1,379,825 | 4,245,725 | ||
| Previous Close | 213.49 | 6.30 | 64.58 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 239.34 | 6.71 | 50.41 | ||
| 20-Day Raw Stochastic | 29.59% | 20.91% | 99.51% | ||
| 20-Day Relative Strength | 42.08% | 44.81% | 80.76% | ||
| Weighted Alpha | -28.46 | -0.43 | +307.49 | ||
| Today's Opinion | 24% Buy | 100% Sell | 100% Buy | ||
| Previous Opinion | 24% Buy | 100% Sell | 100% Buy | ||
| Last Month's Opinion | 88% Buy | 100% Sell | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -6.27% since 04/16/24 | -4.42% since 04/16/24 | +0.08% since 04/16/24 | ||
| Low | 197.43 on 04/22/24 | 6.25 on 04/22/24 | 64.40 on 04/19/24 | ||
| High | 235.91 on 04/17/24 | 6.84 on 04/17/24 | 64.70 on 04/23/24 | ||
| 1-Month | |||||
| %Chg | -12.01% since 03/22/24 | +4.18% since 03/22/24 | +64.08% since 03/22/24 | ||
| Low | 197.43 on 04/22/24 | 6.25 on 04/22/24 | 34.25 on 04/08/24 | ||
| High | 268.22 on 03/28/24 | 7.35 on 04/09/24 | 64.70 on 04/23/24 | ||
| 3-Month | |||||
| %Chg | -4.64% since 01/23/24 | -11.84% since 01/23/24 | +231.37% since 01/23/24 | ||
| Low | 168.25 on 02/09/24 | 5.30 on 03/06/24 | 18.56 on 01/24/24 | ||
| High | 299.98 on 03/15/24 | 9.37 on 02/28/24 | 64.70 on 04/23/24 | ||
| 6-Month | |||||
| %Chg | +73.43% since 10/23/23 | -18.08% since 10/23/23 | +614.05% since 10/23/23 | ||
| Low | 119.76 on 10/27/23 | 5.30 on 03/06/24 | 8.33 on 10/26/23 | ||
| High | 299.98 on 03/15/24 | 12.15 on 12/29/23 | 64.70 on 04/23/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 4,247,809 | 4,331,628 | 4,232,960 | ||
| Shares Outstanding, K | 19,897 | 687,560 | 65,546 | ||
| Annual Sales | 0 | 7,134,500,000 | 58,880,000 | ||
| Annual Net Income | -373,630,000 | 131,340,000 | -32,180,000 | ||
| Last Quarter Sales | 0 | 2,025,030,000 | 30,850,000 | ||
| Last Quarter Net Income | -112,190,000 | 125,920,000 | 5,960,000 | ||
| 60-Month Beta | -0.47 | 0.56 | 1.14 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -5.68 on 02/28/24 | 0.09 on 07/27/23 | 0.15 on 03/18/24 | ||
| Latest Earnings Date | 05/14/24 | 03/05/24 | 05/09/24 | ||
| Most Recent Dividend | N/A | 0.370 on 06/03/21 | N/A | ||
| Next Ex-Dividends Date | N/A | 06/03/21 | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||